| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Your Most Important Investment |
|
Main Subject - Your Most Important Investment
"Imagine a company spending one-third of the revenue on a capital investment or an interest payment and never add According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ressing it with shareholders in their annual report," said Rick Guzzo, a Mercer consultant. "It's unthinkable." ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in Mercer Human Resource Consulting, a unit of insurance brokerage Marsh &McLennan, conducted a Two Year Study of th lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e 100 largest publicly traded American companies. 25% of the largest publicly traded companies included a platit here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe de equivalent to, "our people are our greatest asset". 20% of the companies actually included human capital cont d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ribution to business success in the annual reports.
Budgets track the expense of employees, benefits, travel an ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc d entertainment. How do you measure contributions and impact of personal performance? What is the impact to rev easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nue, risk or cost control if the human asset is missing or not functional for an extended time? What would it co nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically st to replace them and train someone else? How long to train, how much experience lost and how much productivity and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ would you lose? If you invest time and money to improve the efficiency of your most valuable asset, human capita ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi , how will you measure the Return on Investment? How do you communicate the value of personal performance on a r ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a egular and frequent basis? The biggest impact to controlling costs, generating revenue and operating the busines dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s is the time and talent of the individuals. Success is the result of collaborative individual performance. Measu cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin re, monitor and invest appropriately in the biggest impact to your business. If the people thrive then the busine tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s will follow. ______________________________________________________ Words of Wisdom "Good people are in shor t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel t supply. Whether you're an investor, a company owner, or someone strategically tying to figure out what to do in ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust business, you need to pay more attention to employee motivation and human relations."
- Esther Dyson, Chairwoma y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products , EDventure Holdings "Don't try to change people. Instead, work to improve them." - Doug Blevins, performance c . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de oach for professional athletes "You're only as good as your people, that's why the war for talent is intense." elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip
- Thomas Weisel, founder and CEO, Thomas Weisel Partners _____________________________________________________ tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Pursue Your Passion With Legal Office Technology Change Management and the Psychology of Change Considered Lessons for Life: Corporate Crime; What Happened to those Boy Scouts?
|